Valuation Amgen Inc.

Stocks

Real-time Estimate Cboe BZX Other stock markets 08:42:43 05/08/2026 pm IST			5-day change	1st Jan Change
408.98 ^USD	+4.86%		+6.83%	+26.52%

07:25pm	Bernstein Adjusts Price Target on Amgen to $345 From $335, Maintains Market Perform Rating	MT
07:09pm	UBS Adjusts Price Target on Amgen to $440 From $420, Maintains Buy Rating	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	1,26,718	1,40,139	1,54,142	1,40,103	1,76,250	2,11,001	-	-
Change	-	10.59%	9.99%	-9.11%	25.8%	19.72%	-	-
Enterprise Value (EV) ¹	1,51,990	1,69,779	2,07,811	1,88,229	2,21,725	2,51,813	2,47,094	2,40,903
Change	-	11.7%	22.4%	-9.42%	17.8%	13.57%	-1.87%	-2.51%
P/E	21.9x	21.7x	23.1x	34.5x	23x	24.3x	23.1x	22.3x
PBR	18.7x	38.3x	24.7x	23.8x	20.4x	16.7x	16.3x	13.4x
PEG	-	1.2x	7.36x	-0.9x	0.3x	1.9x	4.56x	6.5x
Capitalization / Revenue	4.88x	5.32x	5.47x	4.19x	4.8x	5.45x	5.37x	5.22x
EV / Revenue	5.85x	6.45x	7.37x	5.63x	6.03x	6.5x	6.29x	5.96x
EV / EBITDA	9.61x	10.5x	11.9x	9.13x	10.4x	11.3x	11.4x	11.1x
EV / EBIT	12.2x	13.3x	15.5x	12.5x	13.7x	15x	14.3x	13.6x
EV / FCF	18.1x	19.3x	28.2x	18.1x	27.4x	19.6x	16.7x	15.8x
FCF Yield	5.51%	5.17%	3.54%	5.52%	3.65%	5.11%	5.99%	6.33%
Dividend per Share ²	7.04	7.76	8.52	9	9.52	10.09	10.66	11.12
Rate of return	3.13%	2.95%	2.96%	3.45%	2.91%	2.59%	2.73%	2.85%
EPS ²	10.28	12.11	12.49	7.56	14.23	16.06	16.87	17.45
Distribution rate	68.5%	64.1%	68.2%	119%	66.9%	62.8%	63.2%	63.7%
Net sales ¹	25,979	26,323	28,190	33,424	36,751	38,715	39,270	40,421
EBITDA ¹	15,822	16,178	17,470	20,620	21,370	22,257	21,703	21,712
EBIT ¹	12,424	12,761	13,399	15,028	16,203	16,811	17,240	17,774
Net income ¹	5,893	6,552	6,717	4,090	7,711	8,689	9,033	9,439
Net Debt ¹	25,272	29,640	53,669	48,126	45,475	40,812	36,093	29,902
Reference price ²	224.97	262.64	288.02	260.64	327.31	390.02	390.02	390.02
Nbr of stocks (in thousands)	5,63,266	5,33,579	5,35,178	5,37,533	5,38,481	5,41,000	-	-
Announcement Date	07/02/22	31/01/23	06/02/24	04/02/25	03/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
AMGEN INC.	25.61x	6.68x	11.78x	2.59%	21TCr
ELI LILLY AND COMPANY	34.02x	11.84x	24.88x	0.61%	99TCr
JOHNSON & JOHNSON	28.36x	6.26x	17.51x	2.11%	61TCr
ABBVIE INC.	31.72x	7.19x	14.9x	2.84%	43TCr
ROCHE HOLDING AG	19.93x	4.73x	11.72x	2.79%	35TCr
NOVARTIS AG	21.85x	5.66x	14.11x	2.84%	29TCr
ASTRAZENECA PLC	20.2x	4.19x	11.86x	2.11%	24TCr
NOVO NORDISK A/S	13.52x	5.15x	10.43x	3.7%	21TCr
GILEAD SCIENCES, INC.	-48.74x	5.83x	32.22x	2.44%	17TCr
PFIZER INC.	13.25x	3.14x	7.99x	6.77%	14TCr
Average	15.97x	6.07x	15.74x	2.88%	36.63TCr
Weighted average by Cap.	23.28x	7.37x	17.56x	2.23%